Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Advanced Drainage Systems
WMS
$10.6B
| $8.73M | 0.01% |
75,500
-51,900
| -41% | -$7.2M |
|
1102
Enact Holdings
ACT
$6.61B
| $8.73M | 0.01% |
269,509
-28,500
| -10% | -$986K |
|
1103
Nomura Holdings
NMR
$28.3B
| $8.72M | 0.01% |
1,505,837
+63,318
| +4% | +$359K |
|
1104
OneMain Financial
OMF
$7.2B
| $8.71M | 0.01% |
167,100
+36,400
| +28% | +$1.89M |
|
1105
Stewart Information Services
STC
$2.06B
| $8.71M | 0.01% |
129,000
-23,300
| -15% | -$1.67M |
|
1106
Anika Therapeutics
ANIK
$258M
| $8.7M | 0.01% |
528,517
-45,712
| -8% | -$902K |
|
1107
Embotelladora Andina Series B
AKO.B
$4.74B
| $8.68M | 0.01% |
471,981
-13,400
| -3% | -$244K |
|
|
APLS
1108
DELISTED
Apellis Pharmaceuticals
APLS
| $8.68M | 0.01% |
271,913
-100,418
| -27% | -$3.02M |
|
|
DCH
1109
Dauch Corp
DCH
$1.34B
| $8.66M | 0.01% |
1,484,599
+224,200
| +18% | +$1.4M |
|
1110
Genie Energy
GNE
$367M
| $8.65M | 0.01% |
554,985
-15,500
| -3% | -$243K |
|
1111
RE/MAX Holdings
RMAX
$193M
| $8.63M | 0.01% |
808,369
+19,969
| +3% | +$240K |
|
1112
New Jersey Resources
NJR
$5.84B
| $8.58M | 0.01% |
184,000
+27,900
| +18% | +$1.32M |
|
1113
ODDITY Tech
ODD
$654M
| $8.56M | 0.01% |
203,800
-65,100
| -24% | -$2.8M |
|
1114
Protagonist Therapeutics
PTGX
$8.79B
| $8.54M | 0.01% |
221,167
+77,000
| +53% | +$3.36M |
|
1115
SolarEdge
SEDG
$2.51B
| $8.54M | 0.01% |
627,700
+278,200
| +80% | +$4.28M |
|
1116
Uranium Energy
UEC
$4.75B
| $8.52M | 0.01% |
+1,274,066
| New | +$9.75M |
|
1117
Middlesex Water
MSEX
$1.08B
| $8.48M | 0.01% |
161,213
-26,387
| -14% | -$1.66M |
|
|
BFIN
1118
DELISTED
BankFinancial
BFIN
| $8.47M | 0.01% |
666,887
-18,400
| -3% | -$230K |
|
1119
WSFS Financial
WSFS
$4.12B
| $8.44M | 0.01% |
158,926
-3,029
| -2% | -$165K |
|
1120
TaskUs
TASK
$556M
| $8.43M | 0.01% |
497,623
+32,500
| +7% | +$466K |
|
1121
Ares Management
ARES
$28.9B
| $8.43M | 0.01% |
+47,600
| New | +$8.12M |
|
1122
Target Hospitality
TH
$1.51B
| $8.41M | 0.01% |
870,124
+14,992
| +2% | +$125K |
|
1123
Lincoln National
LNC
$8.73B
| $8.4M | 0.01% |
264,874
-19,000
| -7% | -$633K |
|
1124
Affiliated Managers Group
AMG
$9.69B
| $8.4M | 0.01% |
45,400
-54,400
| -55% | -$10.2M |
|
|
HDSN
1125
Hudson Technologies
HDSN
$254M
| $8.38M | 0.01% |
1,502,150
+246,000
| +20% | +$1.62M |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.